Premium
Naturalistic conceptions of genetic optimism and precision psychiatry among those at clinical high‐risk for psychosis
Author(s) -
Blasco Drew,
Stortz Saige William,
Grivel Margaux MarieRose,
Dishy Gabriella A.,
Samuel Shana S.,
Pilla David,
Crump Francesca M.,
Lieff Sarah A.,
Williams Jourdan,
Phoummavong Phetsamone,
Guo Xufei,
Brucato Gary,
Girgis Ragy R.,
Yang Lawrence H.
Publication year - 2021
Publication title -
early intervention in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.087
H-Index - 45
eISSN - 1751-7893
pISSN - 1751-7885
DOI - 10.1111/eip.12983
Subject(s) - optimism , genetic testing , psychosis , precision medicine , psychology , psychiatry , clinical psychology , medicine , psychotherapist , pathology
Aim Fuelled by genomics advances, recent emphasis on the concept of “precision medicine,” and public optimism towards genetic advances, it is important to understand how those who are considered to be at clinical high‐risk for psychosis (CHR) perceive possible benefits of genetic testing to inform future stakeholder education efforts. Methods Semistructured interviews were completed with 20 participants who met CHR criteria. Coding for genetic optimism was completed. Results Participants endorsed many conceptualizations of the link between genetics, the development of psychosis, and the benefits of genetic testing. Specifically, themes emerged surrounding how genetic testing may lead to greater genetic knowledge and tailored treatment. Conclusions Our results demonstrate that CHR participants generally endorse several precision psychiatry concepts, including how genetic testing may lead to tailored treatment advances. This knowledge may aid development of best communication practices regarding forthcoming genetic advances in diagnosis and treatment among CHR.